Concepedia

Sheng‐Yu Ku

SK

32

Publications

3.9K

Citations

24

H-Index

2013

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Roswell Park Comprehensive Cancer Center

Harvard University

Cornell University

Brigham and Women's Hospital

Sheng‐Yu Ku is an author at Dana-Farber Cancer Institute specializing in medicine, cell biology, and tumor biology.

ORCID

Top concepts

Publications per year

2013–2025

32

Publications

32

<i>Rb1</i> and <i>Trp53</i> cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance

Sheng‐Yu Ku, Spencer R. Rosario, Yanqing Wang et al. · Science · 2017 · 1.1K citations

<i>SOX2</i> promotes lineage plasticity and antiandrogen resistance in <i>TP53</i> - and <i>RB1</i> -deficient prostate cancer

Ping Mu, Zeda Zhang, Matteo Benelli et al. · Science · 2017 · 1K citations · Full text

Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer

Himisha Beltran, Alessandro Romanel, Vincenza Conteduca et al. · Journal of Clinical Investigation · 2020 · 188 citations · Full text

Transcriptional mediators of treatment resistance in lethal prostate cancer

Meng Xiao He, Michael S. Cuoco, Jett Crowdis et al. · Nature Medicine · 2021 · 186 citations · Full text

Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer

Sylvan C. Baca, David Y. Takeda, Ji-Heui Seo et al. · Nature Communications · 2021 · 161 citations · Full text

Rows per page

1–5 of 32